Profitability Ratios
| Ratio |
Value |
| GP Margin |
72.4% |
| EBIT Margin |
24.8% |
| EBITDA Margin |
31.8% |
| Operating Margin |
25.5% |
| Pretax Margin |
22.7% |
| Cont. Ops Margin |
19.3% |
| Net Margin |
17.5% |
| Bottom Line Margin |
17.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.82 |
| Quick Ratio |
0.54 |
| Solvency Ratio |
0.178 |
| Cash Ratio |
0.16 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.10 |
| Forward PEG |
0.10 |
| Price/Book |
4.51 |
| Price/Sales |
2.26 |
| Price/FCF |
12.66 |
| Price/Op Cash Flow |
10.32 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2899 |
| Debt/Equity |
1.0820 |
| Debt/Capital |
0.5197 |
| Long-Term Debt/Capital |
0.4732 |
| Financial Leverage |
3.73 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-7.62 |
| Operating Cash Flow Ratio |
0.335 |
| Operating Cash Flow/Sales |
21.9% |
| Free Cash Flow/Operating Cash Flow |
81.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.52 |
| Interest Coverage |
12.1368 |
| Short-Term Operating Cash Flow Coverage |
2.38 |
| Operating Cash Flow Coverage |
0.40 |
| Capital Expenditure Coverage |
5.42 |
| Dividend + Capital Expenditure Coverage |
1.87 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
43.8735% |
| Dividend Yield |
3.4018% |
| Dividend Yield % |
3.4018% |
| Dividend Per Share |
1.2381 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
16.13 |
| EPS |
2.822 |
| Debt/Share |
9.0723 |
| Cash/Share |
1.68 |
| Book Value/Share |
7.90 |
| Tangible BV/Share |
-3.82 |
| Equity/Share |
8.07 |
| Operating Cash Flow/Share |
3.527 |
| Capital Expenditure/Share |
0.651 |
| FCF/Share |
2.876 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.772 |
| Earnings Before Tax/EBIT |
0.888 |
| Price/Fair Value |
4.51 |
| Debt/Market Cap |
0.2399 |
| Effective Tax Rate |
15.0% |
| Enterprise Value Multiple |
8.46 |
GSK - GSK plc